Serotonin Synthesis Inhibitor

This page covers all Serotonin Synthesis Inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Tryptophan Hydroxylase-1 (TPH1).

Targets

Tryptophan Hydroxylase-1 (TPH1)

Marketed (1)

• TELOTRISTAT ETIPRATE · Oncology
  Telotristat etiprate inhibits tryptophan hydroxylase, the rate-limiting enzyme in serotonin synthesis, thereby reducing serotonin levels in the body.

Patent intelligence

• serotonin synthesis inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates